REYOBIQ

By: Plus Therapeutics, Inc.

Pharmaceutical and radiotherapeutic preparations, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancers.


Logo Design and Free Alerts provided by Trademarks On Call, Inc.

Status Alert: On Tuesday, April 29, 2025, the status for the REYOBIQ mark changed to NOTICE OF ALLOWANCE - ISSUED .

On Wednesday, July 31, 2024, a U.S federal trademark application was filed for REYOBIQ by PLUS THERAPEUTICS, INC., 4200 MARATHON BLVD., SUITE 200, AUSTIN, TX.

The USPTO has assigned the REYOBIQ mark the serial number 98675300. The REYOBIQ mark has been filed in the category Pharmaceutical Products.

The owner of the REYOBIQ mark is listed as Plus Therapeutics, Inc., 2710 Reed Rd, Suite 160, Houston, TX. The correspondent for the REYOBIQ mark is Anna Kurian Shaw Hogan Lovells US LLP of 555 13th Street NW, Washington, DC 20004, UNITED STATES. If you have licensing, usage or other questions concerning the REYOBIQ mark, please contact the owner through the listed correspondent.

The description provided for the REYOBIQ mark is Pharmaceutical and radiotherapeutic preparations, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancers.
Word Mark: REYOBIQ
Status: NOTICE OF ALLOWANCE - ISSUED
Status Date: 04/29/2025
Serial Number: 98675300
Filing Date: 07/31/2024
Registration Number: Not Available
Registration Date: Not Available
Goods and Services: Pharmaceutical and radiotherapeutic preparations, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancers
Type Of Mark: Trademark
Register Type: Principal
Published For Opposition Date: 03/04/2025
Current Owner: Plus Therapeutics, Inc.
2710 Reed Rd, Suite 160
Houston, TX 77051
UNITED STATES
Mark Description: Not Available
Mark Drawing Type: Not Available
Design Search: Not Available
Disclaimer: Not Available
Correspondent: Anna Kurian Shaw Hogan Lovells US LLP
555 13th Street NW
Washington, DC 20004
UNITED STATES
   

 

Class Information

International Class(es):005
US Class(es):005, 006, 018, 044, 046, 051, 052
Primary Class:Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class(es) Status:Active
First Use Anywhere: Not Available
First Use In Commerce:Not Available
Retrieve Trademark Documents